Item 7.01. Regulation FD Disclosure.

As previously announced, management of Insmed Incorporated (the "Company") will present at the virtual 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 4:30 p.m. PT (7:30 p.m. ET). A live webcast of the presentation will be accessible through the investor relations section of the Company's website. The slide presentation to be used during the presentation is attached hereto as Exhibit 99.1 and incorporated herein by reference.

On January 6, 2023, in connection with the presentation, the Company has issued a press release, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference. In addition, the slide presentation to be used during the presentation is attached hereto as Exhibit 99.2 and incorporated herein by reference.

The information contained in this Item 7.01, including the exhibits attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

--------------------------------------------------------------------------------

Item 9.01 Financial Statements and Exhibits.





 (d) Exhibits.



Exhibit
  No.      Description

  99.1     Press release issued by Insmed Incorporated on January 6, 2023.

  99.2     Insmed Incorporated J.P. Morgan Healthcare Conference Presentation.
104        Cover Page Interactive Date File (embedded within the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses